Showing results (121-130 of 344) with videos related to
Sort By:
Pageof 35
Joint Bone Spine|January 28, 2015
Treatment of pseudo Felty's syndrome: Is there a place for rituximab?Frank Verhoeven, Xavier Guillot, Clément Prati, et al.Rheumatology International|November 13, 2024
Séraphin (1747-1800), "the facetious hunchback": How ankylosing spondylitis contributed to the success of his shadow puppet theatreClément Prati, Frank Verhoeven, Daniel Wendling, et al.Mediators of Inflammation|January 15, 2011
Elevated adiponectin serum levels in women with systemic autoimmune diseasesEric Toussirot, Béatrice Gaugler, Malika Bouhaddi, et al.Arthritis Research & Therapy|August 13, 2016
Apoptotic cell infusion treats ongoing collagen-induced arthritis, even in the presence of methotrexate, and is synergic with anti-TNF therapyFrancis Bonnefoy, Anna Daoui, Séverine Valmary-Degano, et al.Clinical Rheumatology|August 18, 2010
Thrombin generation in ankylosing spondylitisClément Prati, Evelyne Racadot, Jean-Pierre Cedoz, et al.Rheumatology and Therapy|August 12, 2024
Treatment with Targeted Therapy in Patients with Psoriatic Arthritis and Inadequate Response to Methotrexate: Proposal for a Rational StrategyPhilippe Goupille, Guillermo Carvajal Alegria, Frank Verhoeven, et al.Joint Bone Spine|July 13, 2010
Rheumatoid arthritis and aromatase inhibitorsEwa Bertolini, Hélène Letho-Gyselinck, Clément Prati, et al.Joint Bone Spine|January 27, 2015
Flare in spondyloarthritis: Thresholds of disease activity variationsMarie Godfrin-Valnet, Marc Puyraveau, Clément Prati, et al.Journal of Parkinson'S Disease|June 10, 2026
Gastroparesis in Parkinson's disease: Diagnostic and clinical implications for optimizing pharmacological treatmentQuentin Damiens, Victor Mille, Justin Faure, et al.Expert Review of Clinical Pharmacology|May 19, 2021
Methotrexate and cardiovascular risk in rheumatic diseases:A comprehensive reviewFrank Verhoeven, Clément Prati, Mickaël Chouk, et al.Pageof 35